I recently came across a very important blog post on the use of the novel new blood-thinner, dabigatran (Pradaxa). Fellow Kentucky cardiologist, and frequent TheHeart.org contributor, Dr. Melissa Walton-Shirley wrote this very detailed case presentation involving a cantankerous non-compliant rural patient with AF (atrial fibrillation) that sustained a stroke while “taking†dabigatran. Dr. Walton-Shirley details […]
Category: General Cardiology
Time-out! (After three days of some heavy non-fiction concerning atrial fibrillation, may I lighten up a bit, and have some fun free-lancing about health, exercise and genes?) Here goes… Good health flows from our genes. Our brains focus, eyes peer, adrenals secret, nodes depolarize, ventricles squeeze, valves open, and then close, muscles flex, and relax, bones […]
More than a year ago, I wrote about the amazing educator, Sal Khan. His website, KhanAcademy, has become an educational behemoth. Using colorful and warmly narrated ten-minute YouTube videos, Sal explains–with breathtaking clarity–almost everything you might want or need to know. He made me grin about re-learning how to do a derivative. He even personally […]
When cyclists find out that I am a heart doctor, they most frequently ask about cholesterol numbers. “…My cholesterol is this…What do you think?†“…My doctor wants me to take a statin…But I read that these drugs might lower my functional threshold power 2.014 watts/40km.” All this focus on numbers saddens me. Remember, I am […]
Good morning all. Cycling Wednesday fell prey to the Springtime weather in Kentucky. Right before post time last evening, our power (which means internet) went down when a large thunderstorm rolled through. Here’s what I have for you this week: It is hardly news to say that we need better means to predict who will […]
Wait… Before reading any further, I would like to issue a warning. If your ideas about healthcare delivery are of an older ilk; if you cling white-knuckled to past dogma, please stop reading now. What follows may cause your atria to fibrillate. Last month I wrote that the best tool for treating atrial fibrillation (AF) […]
Almost everything about the new blood-thinning drug, dabigatran (Pradaxa) is novel. In February, I wrote about the drug’s unusually short (thirty-day) expiration time. This week, the FDA has released a new communication concerning dabigatran. It included practical safety tips for patients, pharmacists and doctors, and is nicely summarized by Larry Husten, on Cardiobrief. Here are […]
There are few other medical specialties that boast more guidelines than Cardiology. We don’t say a specific treatment plan was good or bad; we say it was “I, IIa, IIb, or III” Today, a well publicized health story (WSJ, and NY Times) from the Archives of Internal Medicine reported that more than 50 percent of […]
Today, I would like to tell you about the most effective way to treat the most common heart ailment, atrial fibrillation (AF). It’s not the novel anticoagulant drugs. Though it’s obvious that having stroke prevention options other than warfarin represents a significant advance. It’s not burning the left atrium with an ablation catheter. Though it’s […]
This week’s edition of Grand Rounds was hosted by Dr Ed Pullen, a family medicine doctor from Washington state who maintains a highly informational medical blog at www.drpullen.com. As is the usual case for Grand Rounds, there are many great posts that I look forward to reading in more detail this week. I am honored that yours truly […]
It’s heart-wrenching when young athletes die of sudden cardiac death (SCD). This week, the death of Wes Leonard, a Michigan high school star athlete, was especially poignant since he collapsed right after hitting the game-winning shot. This sort of tragedy occurs about one hundred times each year in America. That’s a lot of sadness. The […]